NCT05178888 2025-02-11Adagrasib in Combination With Palbociclib in Patients With Advanced Solid Tumors (KRYSTAL-16)Mirati Therapeutics Inc.Phase 1 Completed11 enrolled
NCT02022982 2024-03-19PALBOCICLIB + PD-0325901 for NSCLC & Solid TumorsDana-Farber Cancer InstitutePhase 1 Completed60 enrolled
NCT03965845 2022-09-19A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid TumorsCalithera Biosciences, IncPhase 1/2 Completed53 enrolled